02198nas a2200241   4500008004100000245009300041210006900134260000800203300001100211490000700222520140600229653001701635653002101652653002301673653002401696653001701720100002101737700001801758700002001776700001701796700001901813856012401832       2022                        eng d00aSilk fibroin and recombinant elastin blend nano-coatings for implantable medical devices0 aSilk fibroin and recombinant elastin blend nanocoatings for impl  cDEC  a1048750 v333 a<p>
	Silicone breast implants are conventionally used to reconstruct the shape and size of the breast in breast cancer patients. However, rate of failure of implants due to formation of capsular contracture is significantly high. Recent studies have shown that coating the surface of the implant with a biocompatible polymer can mitigate this risk. Here, we have modified the surface of implant using a biocompatible natural biopolymer silk fibroin (SF). Further, we have developed formulations of SF with a recombinantly produced elastin-like-peptide (ELP) and compared their performance with a known anti-fouling hydrophilic polymer - polyethylene oxide (PEO). Microscopic and spectroscopic characterization confirm the formation of uniform coatings. These coatings have been also characterized for their ability to resists crack formation. Further, the coatings have been evaluated for their biological performance. Our studies show that addition of 25 wt% of ELP to SF significantly enhances the crack resistance for the coatings. In addition, SF/ELP coatings reduce the adsorption of blood plasma proteins by more than 80 %. Preliminary analysis shows that the SF/ELP blend coatings are non-cytotoxic and support adhesion, growth and proliferation of fibroblast cells. The study therefore demonstrates that SF/ELP coatings have the potential to mitigate the risk of breast implant failure.</p>
10aBlood plasma10aCrack resistance10aProtein adsorption10aRecombinant elastin10aSilk fibroin1 aJoseph, Emmanuel1 aKane, Kartiki1 aParekh, Nimisha1 aNisal, Anuya1 aJanorkar, Amol  uhttps://library.ncl.res.in/content/silk-fibroin-and-recombinant-elastin-blend-nano-coatings-implantable-medical-devices02285nas a2200277   4500008004100000022001400041245011300055210006900168260000800237300001200245490000800257520137100265653002801636653002101664653001001685653002801695653002501723100002001748700001901768700001801787700002001805700001701825700002201842700002001864856012301884       2022                        eng d  a0141-813000aSuperior processability of Antheraea mylitta silk with cryo-milling: performance in bone tissue regeneration0 aSuperior processability of Antheraea mylitta silk with cryomilli  cJUL  a155-1650 v2133 a<p>
	Non-mulberry silk polymers have a promising future in biomedical applications. However, the dissolution of nonmulberry silk fiber is a still challenge and this poor processability has limited the use of this material. Here, we report a unique protocol to process the Antheraea mylitta (AM) silk fiber. We have shown that the cryo-milling of silk fiber reduces the beta sheet content by more than 10% and results in an SF powder that completely dissolves in routine solvents like trifluoroacetic acid (TFA) within few hours to form highly concentrated solutions (\~20 wt %). Further, these solutions can be processed using conventional processing techniques such as electrospinning to form 3D scaffolds. Bombyx mori (BM) silk was used as a control sample in the study. In-vitro studies were also performed to monitor cell adhesion and proliferation and hMSCs differentiation into osteogenic lineage. Finally, the osteogenic potential of the scaffolds was also evaluated by a 4-week implantation study in rat calvarial model. The in-vitro and in-vivo results show that the processing techniques do not affect the biocompatibility of the material and the AM scaffolds support bone regeneration. Our results, thus, show that cryo-milling facilitates enhanced processability of non-mulberry silk and therefore expands its potential in biomedical applications.</p>
10aBone tissue engineering10aCalvarial defect10ahMSCs10aNon-mulberry silk fiber10aProcessing technique1 aParekh, Nimisha1 aBijosh, C., K.1 aKane, Kartiki1 aPanicker, Alaka1 aNisal, Anuya1 aWangikar, Pralhad1 aAgawane, Sachin  uhttps://library.ncl.res.in/content/superior-processability-antheraea-mylitta-silk-cryo-milling-performance-bone-tissue